Financhill
Sell
32

SENS Quote, Financials, Valuation and Earnings

Last price:
$0.50
Seasonality move :
2.83%
Day range:
$0.49 - $0.50
52-week range:
$0.25 - $1.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
13.76x
P/B ratio:
9.24x
Volume:
4.9M
Avg. volume:
5.8M
1-year change:
6.56%
Market cap:
$325.1M
Revenue:
$22.5M
EPS (TTM):
-$0.11

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
SENS
Senseonics Holdings
$6.1M -$0.02 21.33% -33.33% $1.70
ABT
Abbott Laboratories
$11.1B $1.26 6.75% 41.8% $141.59
CATX
Perspective Therapeutics
$170.4K -$0.29 -- -55.87% $14.1071
ELMD
Electromed
$16.4M -- 12.26% -- $33.50
OM
Outset Medical
$29.4M -$0.98 7.36% -90.13% $26.50
XTNT
Xtant Medical Holdings
$31.4M -$0.02 4.73% -33.33% $1.75
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
SENS
Senseonics Holdings
$0.50 $1.70 $325.1M -- $0.00 0% 13.76x
ABT
Abbott Laboratories
$132.02 $141.59 $229.7B 17.12x $0.59 1.73% 5.45x
CATX
Perspective Therapeutics
$3.9800 $14.1071 $295.4M -- $0.00 0% 28.05x
ELMD
Electromed
$19.08 $33.50 $160M 24.15x $0.00 0% 2.79x
OM
Outset Medical
$19.39 $26.50 $343.6M -- $0.00 0% 0.73x
XTNT
Xtant Medical Holdings
$0.69 $1.75 $95.9M -- $0.00 0% 0.77x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
SENS
Senseonics Holdings
49.83% -1.350 8.15% 6.20x
ABT
Abbott Laboratories
21.34% 0.677 6.18% 1.27x
CATX
Perspective Therapeutics
-- 1.363 -- --
ELMD
Electromed
-- 2.259 -- 4.79x
OM
Outset Medical
35.65% 3.389 47.09% 6.60x
XTNT
Xtant Medical Holdings
43.24% 1.491 51.14% 0.96x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
SENS
Senseonics Holdings
$1.5M -$13.5M -137.35% -1761.77% -205.05% -$16.5M
ABT
Abbott Laboratories
$5.9B $1.7B 23.5% 31.31% 18.43% $933M
CATX
Perspective Therapeutics
-- -$21.8M -- -- -- -$26.2M
ELMD
Electromed
$12.2M $2.1M 16.57% 16.57% 13.65% $2.2M
OM
Outset Medical
$11.1M -$16.4M -44.16% -140.06% -74.31% -$25.8M
XTNT
Xtant Medical Holdings
$20.2M $1.1M -15.44% -26.62% 3.28% $87K

Senseonics Holdings vs. Competitors

  • Which has Higher Returns SENS or ABT?

    Abbott Laboratories has a net margin of -227.89% compared to Senseonics Holdings's net margin of 12.79%. Senseonics Holdings's return on equity of -1761.77% beat Abbott Laboratories's return on equity of 31.31%.

    Company Gross Margin Earnings Per Share Invested Capital
    SENS
    Senseonics Holdings
    24.05% -$0.02 $70.2M
    ABT
    Abbott Laboratories
    56.86% $0.76 $62.3B
  • What do Analysts Say About SENS or ABT?

    Senseonics Holdings has a consensus price target of $1.70, signalling upside risk potential of 242.12%. On the other hand Abbott Laboratories has an analysts' consensus of $141.59 which suggests that it could grow by 7.25%. Given that Senseonics Holdings has higher upside potential than Abbott Laboratories, analysts believe Senseonics Holdings is more attractive than Abbott Laboratories.

    Company Buy Ratings Hold Ratings Sell Ratings
    SENS
    Senseonics Holdings
    1 1 0
    ABT
    Abbott Laboratories
    12 9 0
  • Is SENS or ABT More Risky?

    Senseonics Holdings has a beta of 0.926, which suggesting that the stock is 7.434% less volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.731, suggesting its less volatile than the S&P 500 by 26.93%.

  • Which is a Better Dividend Stock SENS or ABT?

    Senseonics Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Abbott Laboratories offers a yield of 1.73% to investors and pays a quarterly dividend of $0.59 per share. Senseonics Holdings pays -- of its earnings as a dividend. Abbott Laboratories pays out 28.62% of its earnings as a dividend. Abbott Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios SENS or ABT?

    Senseonics Holdings quarterly revenues are $6.3M, which are smaller than Abbott Laboratories quarterly revenues of $10.4B. Senseonics Holdings's net income of -$14.3M is lower than Abbott Laboratories's net income of $1.3B. Notably, Senseonics Holdings's price-to-earnings ratio is -- while Abbott Laboratories's PE ratio is 17.12x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Senseonics Holdings is 13.76x versus 5.45x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SENS
    Senseonics Holdings
    13.76x -- $6.3M -$14.3M
    ABT
    Abbott Laboratories
    5.45x 17.12x $10.4B $1.3B
  • Which has Higher Returns SENS or CATX?

    Perspective Therapeutics has a net margin of -227.89% compared to Senseonics Holdings's net margin of --. Senseonics Holdings's return on equity of -1761.77% beat Perspective Therapeutics's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    SENS
    Senseonics Holdings
    24.05% -$0.02 $70.2M
    CATX
    Perspective Therapeutics
    -- -$0.25 --
  • What do Analysts Say About SENS or CATX?

    Senseonics Holdings has a consensus price target of $1.70, signalling upside risk potential of 242.12%. On the other hand Perspective Therapeutics has an analysts' consensus of $14.1071 which suggests that it could grow by 254.45%. Given that Perspective Therapeutics has higher upside potential than Senseonics Holdings, analysts believe Perspective Therapeutics is more attractive than Senseonics Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    SENS
    Senseonics Holdings
    1 1 0
    CATX
    Perspective Therapeutics
    10 1 0
  • Is SENS or CATX More Risky?

    Senseonics Holdings has a beta of 0.926, which suggesting that the stock is 7.434% less volatile than S&P 500. In comparison Perspective Therapeutics has a beta of 1.177, suggesting its more volatile than the S&P 500 by 17.701%.

  • Which is a Better Dividend Stock SENS or CATX?

    Senseonics Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Senseonics Holdings pays -- of its earnings as a dividend. Perspective Therapeutics pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SENS or CATX?

    Senseonics Holdings quarterly revenues are $6.3M, which are larger than Perspective Therapeutics quarterly revenues of --. Senseonics Holdings's net income of -$14.3M is higher than Perspective Therapeutics's net income of -$18.2M. Notably, Senseonics Holdings's price-to-earnings ratio is -- while Perspective Therapeutics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Senseonics Holdings is 13.76x versus 28.05x for Perspective Therapeutics. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SENS
    Senseonics Holdings
    13.76x -- $6.3M -$14.3M
    CATX
    Perspective Therapeutics
    28.05x -- -- -$18.2M
  • Which has Higher Returns SENS or ELMD?

    Electromed has a net margin of -227.89% compared to Senseonics Holdings's net margin of 12.06%. Senseonics Holdings's return on equity of -1761.77% beat Electromed's return on equity of 16.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    SENS
    Senseonics Holdings
    24.05% -$0.02 $70.2M
    ELMD
    Electromed
    77.97% $0.21 $43.9M
  • What do Analysts Say About SENS or ELMD?

    Senseonics Holdings has a consensus price target of $1.70, signalling upside risk potential of 242.12%. On the other hand Electromed has an analysts' consensus of $33.50 which suggests that it could grow by 75.58%. Given that Senseonics Holdings has higher upside potential than Electromed, analysts believe Senseonics Holdings is more attractive than Electromed.

    Company Buy Ratings Hold Ratings Sell Ratings
    SENS
    Senseonics Holdings
    1 1 0
    ELMD
    Electromed
    2 0 0
  • Is SENS or ELMD More Risky?

    Senseonics Holdings has a beta of 0.926, which suggesting that the stock is 7.434% less volatile than S&P 500. In comparison Electromed has a beta of 0.413, suggesting its less volatile than the S&P 500 by 58.696%.

  • Which is a Better Dividend Stock SENS or ELMD?

    Senseonics Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Senseonics Holdings pays -- of its earnings as a dividend. Electromed pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SENS or ELMD?

    Senseonics Holdings quarterly revenues are $6.3M, which are smaller than Electromed quarterly revenues of $15.7M. Senseonics Holdings's net income of -$14.3M is lower than Electromed's net income of $1.9M. Notably, Senseonics Holdings's price-to-earnings ratio is -- while Electromed's PE ratio is 24.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Senseonics Holdings is 13.76x versus 2.79x for Electromed. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SENS
    Senseonics Holdings
    13.76x -- $6.3M -$14.3M
    ELMD
    Electromed
    2.79x 24.15x $15.7M $1.9M
  • Which has Higher Returns SENS or OM?

    Outset Medical has a net margin of -227.89% compared to Senseonics Holdings's net margin of -86.66%. Senseonics Holdings's return on equity of -1761.77% beat Outset Medical's return on equity of -140.06%.

    Company Gross Margin Earnings Per Share Invested Capital
    SENS
    Senseonics Holdings
    24.05% -$0.02 $70.2M
    OM
    Outset Medical
    37.19% -$3.66 $264M
  • What do Analysts Say About SENS or OM?

    Senseonics Holdings has a consensus price target of $1.70, signalling upside risk potential of 242.12%. On the other hand Outset Medical has an analysts' consensus of $26.50 which suggests that it could grow by 36.67%. Given that Senseonics Holdings has higher upside potential than Outset Medical, analysts believe Senseonics Holdings is more attractive than Outset Medical.

    Company Buy Ratings Hold Ratings Sell Ratings
    SENS
    Senseonics Holdings
    1 1 0
    OM
    Outset Medical
    3 2 0
  • Is SENS or OM More Risky?

    Senseonics Holdings has a beta of 0.926, which suggesting that the stock is 7.434% less volatile than S&P 500. In comparison Outset Medical has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock SENS or OM?

    Senseonics Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Outset Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Senseonics Holdings pays -- of its earnings as a dividend. Outset Medical pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SENS or OM?

    Senseonics Holdings quarterly revenues are $6.3M, which are smaller than Outset Medical quarterly revenues of $29.8M. Senseonics Holdings's net income of -$14.3M is higher than Outset Medical's net income of -$25.8M. Notably, Senseonics Holdings's price-to-earnings ratio is -- while Outset Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Senseonics Holdings is 13.76x versus 0.73x for Outset Medical. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SENS
    Senseonics Holdings
    13.76x -- $6.3M -$14.3M
    OM
    Outset Medical
    0.73x -- $29.8M -$25.8M
  • Which has Higher Returns SENS or XTNT?

    Xtant Medical Holdings has a net margin of -227.89% compared to Senseonics Holdings's net margin of 0.18%. Senseonics Holdings's return on equity of -1761.77% beat Xtant Medical Holdings's return on equity of -26.62%.

    Company Gross Margin Earnings Per Share Invested Capital
    SENS
    Senseonics Holdings
    24.05% -$0.02 $70.2M
    XTNT
    Xtant Medical Holdings
    61.52% -- $77.3M
  • What do Analysts Say About SENS or XTNT?

    Senseonics Holdings has a consensus price target of $1.70, signalling upside risk potential of 242.12%. On the other hand Xtant Medical Holdings has an analysts' consensus of $1.75 which suggests that it could grow by 154.18%. Given that Senseonics Holdings has higher upside potential than Xtant Medical Holdings, analysts believe Senseonics Holdings is more attractive than Xtant Medical Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    SENS
    Senseonics Holdings
    1 1 0
    XTNT
    Xtant Medical Holdings
    1 0 1
  • Is SENS or XTNT More Risky?

    Senseonics Holdings has a beta of 0.926, which suggesting that the stock is 7.434% less volatile than S&P 500. In comparison Xtant Medical Holdings has a beta of -0.139, suggesting its less volatile than the S&P 500 by 113.918%.

  • Which is a Better Dividend Stock SENS or XTNT?

    Senseonics Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Senseonics Holdings pays -- of its earnings as a dividend. Xtant Medical Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SENS or XTNT?

    Senseonics Holdings quarterly revenues are $6.3M, which are smaller than Xtant Medical Holdings quarterly revenues of $32.9M. Senseonics Holdings's net income of -$14.3M is lower than Xtant Medical Holdings's net income of $58K. Notably, Senseonics Holdings's price-to-earnings ratio is -- while Xtant Medical Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Senseonics Holdings is 13.76x versus 0.77x for Xtant Medical Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SENS
    Senseonics Holdings
    13.76x -- $6.3M -$14.3M
    XTNT
    Xtant Medical Holdings
    0.77x -- $32.9M $58K

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Microsoft Be a $5 Trillion Stock?
Will Microsoft Be a $5 Trillion Stock?

Microsoft’s market capitalization sits near $3.73 trillion today. To clear the…

Where Will C3.ai Stock Be in 1 Year?
Where Will C3.ai Stock Be in 1 Year?

C3 .ai (NYSE: AI) has been the poster child for “hype versus execution.”…

What Is the Ceiling for IONQ Stock?
What Is the Ceiling for IONQ Stock?

IonQ (NYSE:IONQ) is a quantum computing startup that, like many…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
58
INKT alert for Jul 12

MiNK Therapeutics [INKT] is up 727.94% over the past day.

Buy
51
NEGG alert for Jul 12

Newegg Commerce [NEGG] is up 74.03% over the past day.

Buy
68
ATRO alert for Jul 12

Astronics [ATRO] is up 16.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock